Desipramine enhances the ability of paliperidone to decrease alcohol drinking

Journal of Psychiatric Research
David T ChauAlan I Green

Abstract

Alcohol use disorder commonly occurs in patients with schizophrenia and dramatically worsens their course. The atypical antipsychotic clozapine has been associated with reduced drinking in these patients, but its toxicity reduces its use. We have attempted to create a clozapine-like drug by combining agents that capture components of clozapine's pharmacologic action, including its weak dopamine D2 blockade and noradrenergic modulation. The current study assessed whether paliperidone, a dopamine D2 receptor and adrenergic alpha-2 receptor antagonist like clozapine, would attenuate alcohol drinking in the alcohol-preferring P rat and the Syrian golden hamster, and whether desipramine, a norepinephrine reuptake inhibitor, would potentiate the ability of paliperidone to attenuate alcohol drinking in the P rat and the Syrian golden hamster. Daily subcutaneous injections of paliperidone (5 mg/kg for the rat; 1 mg/kg for the hamster) over 20 days slightly and transiently attenuated initiation of alcohol consumption in both animals. Desipramine (3 mg/kg) or lower doses of paliperidone alone did not affect alcohol drinking. However, the combination of desipramine (3 mg/kg) and paliperidone essentially prevented initiation of alcohol dri...Continue Reading

References

Mar 1, 1979·Pharmacology, Biochemistry, and Behavior·R A HarrisJ Case
Nov 21, 1990·JAMA : the Journal of the American Medical Association·D A RegierF K Goodwin
Jan 1, 1989·Schizophrenia Bulletin·M A TestK Ripp
May 1, 1987·Pharmacology, Biochemistry, and Behavior·J N Nobrega, D V Coscina
Jan 1, 1981·Addictive Behaviors·A I AltermanE Murphy
Apr 1, 1996·The Journal of Nervous and Mental Disease·A F LehmanJ L Johnson
May 1, 1996·Schizophrenia Research·S GuptaE A Haffke
Aug 1, 1996·Psychiatric Services : a Journal of the American Psychiatric Association·R R OwenB J Cuffel
Jul 11, 1998·Alcoholism, Clinical and Experimental Research·S L Morzorati
Oct 13, 1998·Psychopharmacology·R Z Litten, J P Allen
May 18, 2000·Biochemical and Biophysical Research Communications·W M KeungO Lazo
Jul 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Igor ElmanAlan Breier
May 12, 2004·Chemico-biological Interactions·Katalin MonostoryLászló Vereczkey
Sep 29, 2004·Psychiatry Research·Alan I GreenJoseph J Schildkraut
Apr 28, 2006·International Journal of Adolescent Medicine and Health·Helen J K SableWilliam J McBride
Jun 19, 2007·Journal of Substance Abuse Treatment·Alan I GreenChristopher O'Keefe
Nov 10, 2009·Neuropharmacology·David T ChauAlan I Green
Mar 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emmanuelle Simon O'BrienMickaël Naassila

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Alcohol Use Disorder

Alcohol use disorder involves a pattern of alcohol consumption that includes compulsive use and a loss of control over intake of alcohol. The impact on physical health, socioeconomic factors, and psychiatric health is profound. Find the latest research on alcohol use disorder here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here